Key Findings
The Europe market for the stem cell assay market is anticipated to grow $xx million by 2027 from $ xx million in 2018. During the forecast period of 2019-2027, the growth of the market is presumed to be at a CAGR of 18.40%. The base year considered for the market study is 2018. Rise in the adoption of stem cell assay, the evolvement of technology and increase spending in the stem cell assay market are the key drivers in the Europe stem cell assay market.

Market Insights
The Europe stem cell assay market is segmented on the basis of types of assay, product, kits, application, end-user, and geography. The Europe stem cell assay market by type is segmented into cell viability and toxicity assays, isolation and purification assays, cell identification assays, cell differentiation assays, cell function assays, and cell apoptosis assays. The product of Europe stem cell assay market is segmented into instruments and detection kits. The kits of stem cell assay market are further segmented into adult stem cell kits, human embryonic stem cell kit. The stem cell market by application is further bifurcated into regenerative medicine and therapy development, drug discovery and development and clinical research market. The end-user of the stem cell market is segmented into research institutes and industry research.

The Europe stem cell assay market by geography is segmented into the UK, France, Germany, Spain, Italy and the Rest of Europe. Increasing adoption of stem cell assay, improvement in the technology, high expense in stem cell research are the major drivers for the market growth in the Europe region. The rise in the adoption of stem cell assay for drug screening & testing is one of the major reasons driving industrial research.

Competitive Insights
Merck Millipore (holding company is Merck KGaA), Bio-Rad, Promega Corporation, Cellular Dynamics International (Holding Company Fujifilm), Corning Inc., Stem Cell Technologies, GE Healthcare, R&D Systems, Thermo Fisher, Fibrocell Science Inc., Stryker Corporation, Hemogenix Inc., Takara Holdings Inc., Cell Bio Labs, Inc. and Becton Dickinson are the major market players in the region.